This feasibility study examines the build and operation of a state-of-the-art sterile biopharmaceutical injectable manufacturing plant in Akuse, Ghana. Commissioned by Quintex and developed by a consulting consortium consisting of AMPC International Health Consultants, IQVIA, and PwC Ghana, the proposed facility aims to address local medicine shortages and reduce the country’s heavy 70% reliance on imported pharmaceuticals. The plant is designed to focus on Small Volume Parenterals (SVPs), specifically producing generic and branded liquid medications in vials and prefilled syringes while strictly adhering to global Good Manufacturing Practices (GMP) and environmental standards.